Reeling in an $18 million add-on to the $37 million Series B that it reported last year, Bigfoot Biomedical touted today that it has raised over $90 million in total funding since the Milpitas, Calif.-based company first launched. Investments from Abbott (NYSE:ABT), which has an established partnership with Bigfoot, and other new and existing investors, brought the […]
Bigfoot brings Series B total to $55m with new investment from Abbott
March 28, 2018 By Leave a Comment
This medtech CEO led his company to a $200 million buyout
March 8, 2018 By Leave a Comment
Guiding a company through a merger or an acquisition can test a CEO’s leadership skills. Here’s how NinePoint Medical CEO, Christopher von Jako, led his former medtech company, NeuroTherm, through a deal with St. Jude Medical. When Christopher von Jako assumed the corner office at NeuroTherm in 2013, the company had gone through two other
Hacking pacemakers is good TV, but is it for real?
February 27, 2018 By Leave a Comment
Worry less about bad people hacking pacemakers and other cardiac devices. Worry more about them disrupting hospitals’ communications networks. That’s the major message out of the American College of Cardiology’s Electrophysiology Council, which published an article about cardiac devices earlier this month in the Journal of the American College of Cardiology. The idea that hackers might
Webinar: The top medtech stories of 2017
January 30, 2018 By Leave a Comment
This webinar was presented live on Tuesday, January 30, 2018. Click below to watch on demand. The medtech industry saw its transformation accelerate in 2017: Whether it’s the roster of largest companies, business models or the regulatory environment, times are a-changing. Competition is also heating up in areas including diabetes care and robotic
Abbott, Nevro tout spinal cord stimulation tech
January 16, 2018 By Leave a Comment
Abbott (NYSE:ABT) and Nevro (NYSE:NVRO) touted their spinal cord stimulation technologies at the annual North American Neurological Society meeting in Las Vegas. Two-year data from Abbott’s 42-patient Sunburst study revealed that a majority of patients chose its BurstDR therapy when given the choice during the long-term follow-up period and that stimulation from BurstDR provided pain relief […]
Abbott nabs CMS reimbursement for FreeStyle Libre continuous glucose monitor
January 4, 2018 By Leave a Comment
Abbott (NYSE:ABT) said today that its FreeStyle Libre continuous glucose monitor is now available to Medicare patients, after the Centers for Medicare & Medicaid Services determined that the device can be classified as a therapeutic CGM. The FreeStyle Libre is designed to read glucose levels through a sensor worn on the back of a person’s upper […]
7 top stories that mattered for medtech in 2017
December 29, 2017 By Leave a Comment
The medtech industry saw its transformation accelerate in 2017: Whether it’s the roster of largest companies, business models or the regulatory environment, times are a-changing. Competition is also heating up in areas including diabetes care and robotic surgery. Here are seven stories that mattered for the medical device industry this year. Next>>
Everything you need to know about medical device creation
November 22, 2017 By Leave a Comment
Medtech development is hard. Medical device creation can require manufacturing know-how in areas as wide-ranging as electrical components, high-performance polymers, molding and machining – and that doesn’t even include the required expertise in design, regulatory requirements and achieving reimbursement. The good news is that the companies serving the medical device industry have become specialized experts. Through
How DarioHealth turned the smartphone into a user-friendly glucose monitor
November 14, 2017 By Leave a Comment
When DarioHealth (NSDQ:DRIO) CEO Erez Raphael looks at the medical device world, he sees solutions that were designed by healthcare professionals and doctors – and this presents a stark contrast with the consumer device industry, he pointed out. “We have seen there are a lot of cases, most of the cases in the industry, where the […]
Imagining the future of heart pump technology
October 25, 2017 By Leave a Comment
Since its introduction more than 50 years ago, the left ventricular assist device has evolved from being a temporary solution to a long-term option for patients recovering from heart failure. Now, companies are engineering the LVAD of the future to be smaller and more adaptable for individual patients. Dr. John O’Connell, Abbott For more than
The 11 most innovative medical devices of 2017
October 20, 2017 By 7 Comments
The nominees for the best medical technology of 2017 were recently announced for the 11th Annual Prix Galien USA Awards. The Galien Foundation, the host of the awards, hands out the the Prix Galien Award annually to examples of outstanding biomedical and technology product achievement designed to improve human condition. Before candidates can qualify for
Abbott’s $5B acquisition of Alere set to close tomorrow
October 2, 2017 By Leave a Comment
Abbott (NYSE:ABT) said today it is looking to close its $5 billion acquisition of Alere (NYSE:ALR) tomorrow, saying it has received all regulatory clearances necessary. The Abbott Park, Ill.-based company said the acquisition will establish it as a “global leader in point of care testing,” which it sees as the fastest growing segment of the $50 billion in vitro […]
Why Bigfoot Biomedical’s CEO thinks the diabetes industry has a data problem
September 29, 2017 By Leave a Comment
Bigfoot Biomedical‘s chief executive is excited about Abbott‘s (NYSE:ABT) latest regulatory win – and it’s not just because the two companies have an established partnership. Yesterday, the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring system. It’s the first device of its kind, allowing patients to track their blood glucose levels without the use […]
How Abbott is making good on investor promises
September 22, 2017 By 1 Comment
Abbott (NYSE: ABT) has won FDA approval of MR-compatible ICDs – an indication that it could be making good executing on key priorities it inherited when it acquired St. Jude Medical for $25 billion early this year. The news today “lends incremental credibility to our thesis that ABT can and will have a positive impact on STJ
The 20 Largest Medical Device Companies In the World
September 19, 2017 By 3 Comments
When it comes to the largest medical device companies, it’s a changing cast of players – as demonstrated once again in Medical Design & Outsourcing’s latest Big 100 list. We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in
